ArticleHealth science reports2026
Randomized Controlled Trial on the Effectiveness of a Telehealth Gamification App for Self-Management in Patients With Inflammatory Bowel Disease.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammatory bowel diseases (IBDs) are chronic, relapsing-remitting disorders that significantly impair quality of life and increase healthcare utilization. Although effective therapies are available, suboptimal adherence and insufficient monitoring often compromise disease control. Digital health interventions that incorporate gamification may strengthen patient engagement and promote sustained self-management. Objective: To assess the efficacy of the "My IBD Buddy" gamified mobile telemedicine platform vs. standard care in enhancing clinical and patient-reported outcomes among adults with IBD. Methods: A multicenter, parallel-group, two-arm exploratory randomized controlled trial (RCT) was conducted over 24 weeks. Adults with IBD were randomized to receive either the My IBD Buddy intervention-featuring disease activity tracking, medication adherence support, personalized education, and gamified self-management modules-or standard care. Primary endpoints were disease-specific quality of life and self-efficacy; secondary endpoints included disease knowledge, mental health status, and additional health-related metrics. Results: At week 12, the intervention group exhibited statistically significant improvements in self-efficacy ( Conclusion: A gamified, theory-driven telemedicine platform significantly enhanced patient-reported outcomes, disease knowledge, and engagement in IBD care. These results support incorporating gamified digital self-management solutions into routine clinical practice as a scalable, patient-centered strategy for managing chronic disease. Trial Registration: IRCT20200613047757N1; registered on November 16, 2021. Prospectively registered and accessible via OSF: https://doi.org/10.17605/OSF.IO/AWFY9.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.